(Q30381713)

English

Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

influenza vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Geert Leroux-Roels

11

object named as

Geert Leroux-Roels

0 references

François Roman

2

object named as

François Roman

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

7

object named as

Paul Gillard

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

6

object named as

Mamadou Dramé

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

author name string

Isabel Leroux-Roels

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sheron Forgus

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Cathy Maes

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Fien De Boever

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Robbert van der Most

8

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Marcelle Van Mechelen

9

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Emmanuel Hanon

10

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

14 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

849-857

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Current status and progress of prepandemic and pandemic influenza vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

Update on avian influenza A (H5N1) virus infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

Vaccine adjuvants alter TCR-based selection thresholds.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

Follicular helper T cells as cognate regulators of B cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.017

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.10.017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30381713&oldid=1623538808"